ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

ClinicalTrials.gov ID: NCT00369564

Public ClinicalTrials.gov record NCT00369564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 1:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Glutamic Acid to Decrease Vincristine Toxicity in Children With Cancer

Study identification

NCT ID
NCT00369564
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of South Florida
Other
Enrollment
250 participants

Conditions and interventions

Interventions

  • glutamic acid Drug
  • placebo Other

Drug · Other

Eligibility (public fields only)

Age range
3 Years to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2007
Primary completion
Oct 31, 2012
Completion
Oct 31, 2012
Last update posted
Aug 10, 2021

2007 – 2012

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Lee Cancer Care of Lee Memorial Health System Fort Myers Florida 33901
Butterworth Hospital at Spectrum Health Grand Rapids Michigan 49503-2560
Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota 55404
Hackensack University Medical Center Cancer Center Hackensack New Jersey 07601
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861
Nationwide Children's Hospital Columbus Ohio 43205-2696

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00369564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00369564 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →